Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2005
The purpose of this study is to evaluate whether the HIV vaccine VRC-HIVDNA009-00-VP will be safe in individuals who started antiretroviral therapy during acute HIV-1 infection. The study will also test whether the vaccine can increase the immune system function in these participants.
Epistemonikos ID: c9f9b0ef9acf939fe687ae05f965bcb338c73e25
First added on: Dec 01, 2021